As the pharmaceutical and biotech industries face pending healthcare and biologics legislation, the future of the industry remains in flux. Many companies have generics coming off patent necessitating discussion on new investments, pipeline issues and increased research & development.
On June 22nd, Argyle Executive Forum will host its Leadership in Pharmaceuticals and Biotechnology event, taking place in Manhattan. The event brings together approximately 100 - 115 CEO’s and complementary areas of executive leadership (CFOs, COOs, etc.), from large and midsized pharmaceutical and biotech companies, founders/senior managing partners of investment firms that focus on pharmaceuticals and biotechnology and select advisors.
Please note that the limited seating for members of the advisory community is offered first to those that are supporting the event as sponsors. This event is by invitation only, and an invitation code is required. If you did not receive an invitation but would like to inquire about attendance, please click here.
*The press policy for this event has not yet been finalized. Please note the press policy is set at the individual session level. Some sessions may be on the record, while others are off the record. Please consult the event’s agenda, which will indicate which sessions are off the record. To inquire about media presence, please click here.
Perspectives By:
Mark Altmeyer
President and Chief Executive Officer
Otsuka America Pharmaceutical, Inc.
David H. Donabedian, PhD, MBA
Vice President, Strategic Alliances
US CEEDD, GSK
Chris Garabedian
Vice President, Corporate Strategy
Celgene Corporation
Julius Knowles
Head, Platforms, Strategic Alliances
Novartis Institutes for BioMedical Research
Reid J. Leonard, Ph.D.
Executive Director, Licensing & External Research
Merck Research Laboratories
Rod MacKenzie
Senior Vice President,
Head of Worldwide Research for the PharmaTherapeutics division of Pfizer
Pfizer Inc
Garry Neil, MD
Corporate Vice President, Corporate Office of Science & Technology
Johnson & Johnson
Mark Powell
Senior Vice President, Pharmaceutical Development
Bristol-Myers Squibb
Lesley Russell, MB.Ch.B., MRCP
Executive Vice President & Chief Medical Officer
Cephalon
Hans Vemer
Former Senior Vice President- Women’s Health
Schering-Plough
*Argyle Executive Forum's receptions are by invitation only. Argyle Executive Forum reserves the right to review and approve all attendees. |
